Technology shown to distinguish disease-causing potentially life-threatening Staphylococcus strains from Staphylococcus present due to environmental contamination, supporting more accurate diagnosis, better patient care and healthcare cost savings SALT LAKE CITY, April 06, 2017, GBSN, (GLOBE NEWSWIRE) — Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced that a research article, “A Novel Approach to Eliminate Detection of Contaminating Staphylococcal Species Introduced During Clinical Trial,” was published in PLOS ONE, a peer-reviewed scientific journal. The full article can beRead more
- Vertically integrated cannabis firm Ascend Wellness raises $55 million for expansion
- Lifeline Biotechnologies Updates Shareholders and The Public
- Financial Gravity Selects Securities Transfer Corporation as Transfer Agent
- Wayfair Reports 58% Increase in Direct Retail Sales for Peak Five-Day Holiday Shopping Weekend
- Marijuana tech firm Metrc gets $50M with help from Snoop Dogg, Tiger Global
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More